Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage
Advanced Science · 2024
DOI: 10.1002/advs.202408180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Chengyun Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Techn…. Hauptthemen laut MEDLINE: Copper, Thiazolidines, Cycloaddition Reaction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang University of Technology High-Level Talents Startup Funds, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metal‐mediated chemical transformations are promising approaches to manipulate and regulate proteins in fundamental biological research and therapeutic development. Nevertheless, unlike bond‐forming reactions, the exploration of selective bond cleavage reactions catalyzed by metals that are fully compatible with proteins and living systems remains relatively limited. Here, it is reported that Copper(II)/tris(3‐hydroxypropyltriazolylmethyl)amine (THPTA), commonly used in copper‐catalyzed azide‐alkyne cycloaddition (CuAAC) reaction, can be repurposed as a new bioorthogonal catalyst for thiazolidine (Thz) bond cleavage. This process liberates an α‐oxo‐aldehyde group under physiological conditions, without requiring additional additives. To showcase the utility of this method, this simple catalyst system is coupled with genetic code expansion technology to achieve on‐demand activation of genetically encoded Thz‐caged α‐oxo‐aldehydes, enabling further functionalization of proteins. For the first time, this cell‐compatible Thz uncaging reaction allows for the site‐specific installation of α‐oxo‐aldehydes at the internal positions of proteins in phage and bacterial surface display systems, expanding the chemical space of proteins. Overall, this study expands the toolkit of bioorthogonal catalysts and paves the way for metal‐promoted chemical reactions in living systems, potentially benefiting various applications in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
- Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd, Hangzhou, 310013, China.
- School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
- Lab of Biosystem and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China.
ORCID-Profile: Xiaobao Bi
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang University of Technology High-Level Talents Startup Funds
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- A Project Supported by Scientific Research Fund of Zhejiang Provincial Education Department
Zitieren
APA
Ma, C., Liu, G., Yin, J., Sun, J., Luo, D., Yang, D., Pang, S., Hou, W., Hemu, X., Ye, B., & Bi, X. (2024). Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage. Advanced Science. https://doi.org/10.1002/advs.202408180
Vancouver
Ma C, Liu G, Yin J, Sun J, Luo D, Yang D, et al. Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage. Advanced Science. 2024. doi:10.1002/advs.202408180
BibTeX
@article{Ma2024,
author = {Ma, Chengyun and Liu, Guoqing and Yin, Juan and Sun, Jianan and Luo, Disheng and Yang, Dechun and Pang, Shuo and Hou, Wei and Hemu, Xinya and Ye, Bangce and Bi, Xiaobao},
title = {Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202408180}
}
EUVIMED